← Back to Search

Non-invasive Brain Stimulation

Theta Stimulation Group for Mild Cognitive Impairment

N/A
Waitlist Available
Led By Theodore Zanto, Ph.D.
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-tacs (1-month follow-up), approximately 1 month after baseline
Awards & highlights

Study Summary

This study is evaluating whether a type of non-invasive brain stimulation can improve cognitive control abilities in adults with mild cognitive impairment.

Eligible Conditions
  • Mild Cognitive Impairment

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-tacs (1-month follow-up), approximately 1 month after baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-tacs (1-month follow-up), approximately 1 month after baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Divided Attention Performance
Sustained Attention Performance
Working Memory Performance
Secondary outcome measures
Instrumental Activities of Daily Living (IADL)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Theta Stimulation GroupExperimental Treatment1 Intervention
This group will receive 6 Hz (theta) stimulation
Group II: Delta Stimulation GroupActive Control1 Intervention
This group will receive 1 Hz (delta) stimulation
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcranial alternating current stimulation
2021
N/A
~140

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,498 Previous Clinical Trials
11,936,318 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,665 Previous Clinical Trials
28,005,049 Total Patients Enrolled
Theodore Zanto, Ph.D.Principal InvestigatorUniversity of California, San Francisco
2 Previous Clinical Trials
61 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Enhancing Cognitive Control in Mild Cognitive Impairment Via Non-invasive Brain Stimulation
2021. "Enhancing Cognitive Control in Mild Cognitive Impairment Via Non-invasive Brain Stimulation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04647032.
~7 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top